P-270: GO41036: a Phase Ia/Ib open-label, multicenter study evaluating the safety and pharmacokinetics of tiragolumab in combination with atezolizumab and daratumumab in patients with R/R MM

Autor: Ruppert, Shannon M., Cuchelkar, Vaikunth, Soman, Anisha, Johnson, Diantha, Nouet, Yann
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia August 2022 22 Supplement:S186-S186
Databáze: ScienceDirect